pivotal clinical trial

Atlanta, United States – March 10, 2026 Femasys Inc. has announced the initiation of patient enrollment in the FINALE...

Minneapolis, U.S., and Brisbane, Australia, January 21, 2026 — Anteris Technologies Global Corp. announced the pricing of a $200...

BOSTON | January 7, 2026 — CSA Medical, a U.S.-based medical device company focused on interventional pulmonary therapies, has...

Waltham, Massachusetts & Boulder, Colorado | December 30, 2025 — Cogent Biosciences, Inc. has announced the submission of a...